Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1952 1
1953 1
1962 1
1967 2
1968 1
1969 2
1970 2
1971 4
1972 1
1973 1
1976 3
1977 1
1978 1
1980 2
1982 1
1986 1
1987 1
1988 1
1989 1
1990 3
1992 1
1993 2
1994 3
1995 1
1997 2
1998 1
1999 7
2002 2
2003 1
2004 1
2005 1
2006 4
2007 2
2009 1
2010 1
2012 4
2013 1
2014 3
2015 3
2016 1
2017 2
2018 2
2019 4
2020 1
2021 1
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Lao CD, De Menezes JJ, Dalle S, Arance A, Grob JJ, Srivastava S, Abaskharoun M, Hamilton M, Keidel S, Simonsen KL, Sobiesk AM, Li B, Hodi FS, Long GV; RELATIVITY-047 Investigators. Tawbi HA, et al. N Engl J Med. 2022 Jan 6;386(1):24-34. doi: 10.1056/NEJMoa2109970. N Engl J Med. 2022. PMID: 34986285 Free PMC article. Clinical Trial.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, Dalle S, Schenker M, Chiarion-Sileni V, Marquez-Rodas I, Grob JJ, Butler MO, Middleton MR, Maio M, Atkinson V, Queirolo P, Gonzalez R, Kudchadkar RR, Smylie M, Meyer N, Mortier L, Atkins MB, Long GV, Bhatia S, Lebbé C, Rutkowski P, Yokota K, Yamazaki N, Kim TM, de Pril V, Sabater J, Qureshi A, Larkin J, Ascierto PA; CheckMate 238 Collaborators. Weber J, et al. N Engl J Med. 2017 Nov 9;377(19):1824-1835. doi: 10.1056/NEJMoa1709030. Epub 2017 Sep 10. N Engl J Med. 2017. PMID: 28891423 Free article. Clinical Trial.
NICE 2022 guidelines on the management of melanoma: Update and implications.
Lakshmi A, Shah R, Begaj A, Jayarajan R, Ramachandran S, Morgan B, Faust G, Patel N. Lakshmi A, et al. Among authors: faust g. J Plast Reconstr Aesthet Surg. 2023 Oct;85:401-413. doi: 10.1016/j.bjps.2023.07.026. Epub 2023 Jul 20. J Plast Reconstr Aesthet Surg. 2023. PMID: 37572388 Free article.
GEM: crystal-clear DNA alignment.
Faust GG, Hall IM. Faust GG, et al. Nat Methods. 2012 Dec;9(12):1159-61. doi: 10.1038/nmeth.2256. Nat Methods. 2012. PMID: 23223169 No abstract available.
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
Crabb SJ, Hussain S, Soulis E, Hinsley S, Dempsey L, Trevethan A, Song Y, Barber J, Frew J, Gale J, Faust G, Brock S, McGovern U, Parikh O, Enting D, Sundar S, Ratnayake G, Lees K, Birtle AJ, Powles T, Jones RJ. Crabb SJ, et al. Among authors: faust g. J Clin Oncol. 2023 Jan 1;41(1):54-64. doi: 10.1200/JCO.22.00405. Epub 2022 Aug 12. J Clin Oncol. 2023. PMID: 35960902 Free PMC article. Clinical Trial.
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
Brown JE, Royle KL, Gregory W, Ralph C, Maraveyas A, Din O, Eisen T, Nathan P, Powles T, Griffiths R, Jones R, Vasudev N, Wheater M, Hamid A, Waddell T, McMenemin R, Patel P, Larkin J, Faust G, Martin A, Swain J, Bestall J, McCabe C, Meads D, Goh V, Min Wah T, Brown J, Hewison J, Selby P, Collinson F; STAR Investigators. Brown JE, et al. Among authors: faust g. Lancet Oncol. 2023 Mar;24(3):213-227. doi: 10.1016/S1470-2045(22)00793-8. Epub 2023 Feb 13. Lancet Oncol. 2023. PMID: 36796394 Free article. Clinical Trial.
Runs of homozygosity and testicular cancer risk.
Loveday C, Sud A, Litchfield K, Levy M, Holroyd A, Broderick P, Kote-Jarai Z, Dunning AM, Muir K, Peto J, Eeles R, Easton DF, Dudakia D, Orr N, Pashayan N; UK Testicular Cancer Collaboration; PRACTICAL Consortium; Reid A, Huddart RA, Houlston RS, Turnbull C. Loveday C, et al. Andrology. 2019 Jul;7(4):555-564. doi: 10.1111/andr.12667. Andrology. 2019. PMID: 31310061 Free article.
Chylothorax after blunt trauma.
Seitelman E, Arellano JJ, Takabe K, Barrett L, Faust G, Angus LD. Seitelman E, et al. Among authors: faust g. J Thorac Dis. 2012 Jun 1;4(3):327-30. doi: 10.3978/j.issn.2072-1439.2011.09.03. J Thorac Dis. 2012. PMID: 22754675 Free PMC article.
SpeedSeq: ultra-fast personal genome analysis and interpretation.
Chiang C, Layer RM, Faust GG, Lindberg MR, Rose DB, Garrison EP, Marth GT, Quinlan AR, Hall IM. Chiang C, et al. Among authors: faust gg. Nat Methods. 2015 Oct;12(10):966-8. doi: 10.1038/nmeth.3505. Epub 2015 Aug 10. Nat Methods. 2015. PMID: 26258291 Free PMC article.
90 results